Patient‐related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE

The utility of amyloid positron emission tomography (PET) for the etiological diagnosis of dementia and its impact on functional status of patients in routine care are currently unclear. Here, we describe the design of ENABLE, a randomized controlled two‐armed coverage with evidence development (CED...

Descripción completa

Detalles Bibliográficos
Autores principales: Teipel, Stefan J., Spottke, Annika, Boecker, Henning, Daamen, Marcel, Graf, Erika, Sahlmann, Jörg, Buchert, Ralph, Mohnike, Wolfgang, Mohnike, Konrad, Kurth, Jens, Jessen, Frank, Krause, Bernd J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407881/
https://www.ncbi.nlm.nih.gov/pubmed/37560401
http://dx.doi.org/10.1002/trc2.12383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407881/
https://www.ncbi.nlm.nih.gov/pubmed/37560401
http://dx.doi.org/10.1002/trc2.12383

Ejemplares similares